Cannabis Legalization News Podcast

🌿📢 December 2023 Cannabis Legalization News Update 🌱💨 Join us this month as we dive into the latest developments in the world of cannabis legalization! 🚀 From groundbreaking legislation to industry trends, we've got all the highlights covered. 🎥💡 🔎 In this episode: New Laws and Regulations: What's changed in the cannabis landscape this December? 📜🔍 Licensing Updates: Insights into the latest cannabis licensing processes and how they impact growers and businesses. 🏢🌿 Industry Trends: Exploring the evolving cannabis market and what it means for consumers and investors. 💹🌐 Legal Challenges: A detailed look at the Maryland Hemp Case and its implications for the hemp industry. ⚖️🌿 Expert Opinions: Interviews with industry leaders and policy makers. 🎤🧠 👉 Don't forget to like, share, and subscribe for more monthly cannabis news updates! 🔔 Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj) 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz) 📌 Hashtags: #CannabisNews #LegalizationUpdate #December2023 #CannabisIndustry #HempLegalMatters #GrowersGuide #CannabisLicensing #PolicyChanges #CannabisCommunity

🌱✨ Exciting news for the hemp industry! 🌿💼The recent extension of the Farm Bill means that hemp will continue to flourish and grow bigger in 2024. 🚀📈💥 According to a recent article by Rod Kight, an international hemp and cannabis business law attorney, the "Further Continuing Appropriations and Other Extensions Act, 2024" includes a provision that allows the authorities provided by the Agriculture Improvement Act of 2018 (the 2018 Farm Bill) to continue until September 30, 2024. 📅✍️ This extension is great news for the rapidly expanding hemp industry, which is already making waves with its estimated $28.4 billion market demand. 🌎💰💼 It provides a valuable opportunity for hemp companies to further establish themselves and expand their operations both domestically and internationally. 🌎🚀 Why is this extension important? Well, it allows the industry to continue progressing and bringing cannabis to people in the US. Additionally, it opens doors for hemp companies to tap into international markets, as hemp can cross borders and many current hemp products meet the standards set by countries with emerging cannabis programs. 🌿🌎💼 But hold on, this doesn't mean the hemp industry can rest easy when it comes to politics. In fact, it's more crucial than ever to educate local, state, and national representatives about the importance of hemp and its products. Advocacy and awareness play a vital role in shaping policies that support the growth of this burgeoning industry. 🗣️📚🌿 So, while we eagerly await the arrival of the next Farm Bill in the fall of 2024, let's celebrate this extension that allows hemp to continue thriving and making a positive impact in the world. 🎉🌿🌱 #HempIndustry #FarmBill2024 #HempGrowth #CannabisBusiness (Source: Kight on Cannabis) cannabusiness.lawcannabusiness.law Farm Bill Extension Means Hemp Will Grow Big(ger) in 2024 | Kight on Cannabis In addition to an additional window of time to continue its progress of bringing cannabis to people in the US, the extension will allow hemp companies to expand their sales and operations internationally.

Elections were held this week and yielded some promising results for cannabis in several states. Another state joined the list of those that have legalized cannabis for adult-use, while others approved medical cannabis and cannabis decriminalization. This is a positive step for the progress of cannabis reform in the United States. Although this week’s elections had some great news for cannabis supporters, there is still a lot of work to be done. Also, Congress considers the economic benefit of federal legalization and other top headlines of the week are covered. Tune in to Cannabis Legalization News to stay up-to-date on the latest developments. 🍁🌱🔥🌬️🍃🌳🌞🚬 Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz) #CannabisCommunity #420 #CannabisCulture #Weed #CannabisLovers #CannabisDaily #CannabisLife #StayHigh #Budtenders #MedicalMarijuana #Hemp #Dab #Weedstagram #HighTimes #WeedLovers #Sativa #Indica #CBD #THC #cannabisindustry Cannabis Election Results for 2023 | Cannabis News - CLN Podcast November 2023

The latest bill to federally legalize cannabis was reintroduced to Congress last week calling for the amendment of the Controlled Substance Act. This latest measure, known as the STATES Reform Act is one of several legislative attempts to ease federal restrictions on what is still currently a Schedule I substance. The bipartisan bill sponsored by Senator Nancy Mace was first introduced in 2021 under an equally oppositional house speaker. The New Marijuana Legalization Bill: What You Need To Know | Cannabis News We have yet to see what changes have been made as this version has not been made publicly available at this time. Senator Nancy Mace has been a long time advocate of federal legalization of cannabis. Even though several bills on the subject are under consideration, it remains to be seen which will prevail. It is clear though that the movement for legalization has grown significantly in the last few years and more states are being open to the idea. The STATES Reform Act would serve as a stepping stone towards this goal. The Act seeks to remove cannabis from the Controlled Substances Act (CSA) and allow states to regulate it in their own way. It also aims to create an environment that encourages businesses and individuals to operate legally and provides a pathway for those with convictions related to cannabis offenses. The STATES Act has been seen as a major step forward for the legalization movement, but there is still work to be done. As more states move towards legalizing cannabis, most federal bills such as these take the back burner while Congress seeks to address budget issues prior to another government shutdown. Tune in to hear about this story and the other top stories of the week on Cannabis Legalization News. Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz) #cannabisculture #freetheplant #cannabislegalization

The HHS Letter, issued August 29th 2023, rescheduled cannabis from a Schedule I drug to a Schedule III drug. This move has been widely praised by members of the medical and scientific communities, as it paves the way for further research into the potential medicinal benefits of cannabis. Additionally, it reduces the stigma associated with cannabis use and possession, making it easier for people to access and use medical marijuana products without fear of criminal charges. Ultimately, the HHS Letter is a landmark ruling that shows progress towards more sensible regulations on marijuana and opens up new opportunities for research in this field. It may also become part of a larger trend towards decriminalizing or legalizing recreational marijuana in certain states or at the federal level - something many advocates have long advocated for. Plus more of the top stories of the week with Tom Howard and Miggy 420. #MedicalMarijuana #EndCannabisProhibition #CannabisLegalization #HHSLetter #CannabisAdvocacy Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz)

New research from the Federal Reserve Bank finds that states with legal marijuana see a significant economic boost, but also experience an increase in social costs. The report found that states that legalized marijuana for adults saw moderate economic gains after the policy change was implemented, with the number of jobs directly in the marijuana industry growing from less than 125,000 to more than 425,000 between 2017 and 2022. However, the report also found that states with legal marijuana saw an increase in social costs, including substance use disorders, chronic homelessness, and arrests.

Cannabis News for October 15 2023 | Tom & Miggy on the Road This week Tom & Miggy are on the road and cover new federal workplace guidelines for THC testing do not create any new laws. Rather, they clarify that medical marijuana use is not a protected activity under federal law, and that employers are still able to fire employees for testing positive for THC, even if they have a medical marijuana card.

Cannabis Legalization News for October 2023 The House of Representative had quite the shake-up this week leaving many to wonder how that will impact cannabis policy with the recent proposal by the HHS to reschedule cannabis and efforts to pass the SAFER Banking Act. Currently, marijuana is federally illegal, but legal in some states for medical and/or recreational use. This creates a problem for marijuana businesses, which have difficulty accessing banking services. Federal law prohibits banks from doing business with businesses that are involved in illegal activities. There is bipartisan support for legislation that would allow marijuana businesses to access banking services, but it has not yet been passed. Some Republicans have expressed opposition to the legislation, arguing that it would give legitimacy to an illegal industry. If a new House Speaker is elected who is more supportive of marijuana reform, it could increase the chances of legislation passing that would allow marijuana businesses to access banking services. This would be a major win for the marijuana industry and would make it easier for businesses to operate and grow. a lawsuit that has been filed against the US Department of Health and Human Services (HHS) to compel the release of a letter that the Biden administration sent to the Drug Enforcement Administration (DEA) recommending that marijuana be rescheduled. The letter has not been released publicly, but it is believed to contain the Biden administration's reasoning for why marijuana should be rescheduled and what the DEA should do next. The lawsuit was filed by attorney Matthew Zorn, who argues that the letter is a public record and that HHS is required to release it. The lawsuit also claims that HHS is withholding the letter in order to delay or prevent the DEA from rescheduling marijuana. The DEA currently classifies marijuana as a Schedule I drug, which means that it has a high potential for abuse and no currently accepted medical use. Rescheduling marijuana would make it easier for researchers to study the plant and for patients to access it for medical purposes. The outcome of the lawsuit is uncertain, but it could have a significant impact on the future of marijuana reform in the United States. If the court orders HHS to release the letter, it could put pressure on the DEA to reschedule marijuana. This week we also have news out of Arizona, Illinois, Ohio, New York, and Michigan. We also have guest Matt White joining us. Matt white is the creator behind the Strain Show, the Youtube channel where you can learn everything you ever wanted to know about cannabis. Don't miss this latest episode of Cannabis Legalization News. Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz) #cannabisreform #cannabisindustry #cannabislegalization

The SAFER Act in the Senate | Easy DOT Physicals Dr.Nuesse The Senate Banking Committee voted 14-9 on Wednesday to advance the Secure and Fair Enforcement Regulation (SAFER) Banking Act. This is the first time that a Senate committee has approved a marijuana banking bill, and it is a significant step forward for the cannabis industry. The SAFER Banking Act would allow banks to work with state-legal cannabis businesses without fear of federal penalties. This would provide a number of benefits to the cannabis industry, including: Reduced risk of crime and violence: Cannabis businesses would be able to use banks to deposit and withdraw money, which would reduce the need to keep large amounts of cash on hand. This would make them less of a target for criminals. Increased access to capital: Cannabis businesses would be able to apply for loans and lines of credit from banks, which would help them to grow and expand their operations. Reduced costs: Cannabis businesses would no longer have to pay high fees to use money services businesses (MSBs) to process their financial transactions. The passage of the SAFER Banking Act by the Senate Banking Committee is a positive sign for the cannabis industry. However, it is important to note that the bill still needs to be passed by the full Senate and House of Representatives before it can become law. It is also unclear when the bill will be considered by the full Senate. In the meantime, cannabis businesses will continue to face challenges in accessing banking services. However, the passage of the SAFER Banking Act by the Senate Banking Committee is a sign that progress is being made towards addressing this issue. This week we have guest speaker Dr. Matthew Nuesse joining us. Dr. Nuesse is a Certified Medical Examiner with nearly a decade of experience in drug testing and pre-employment medical examinations. He runs the largest YouTube channel specifically focused on federal drug testing. He co-founded the drug testing education course Exploroacademy.com. We have an all new Name That Strain and other titillating news stories from the week on Cannabis Legalization News. Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz) #medicinalcannabis #cannabis #cannabislegalization

Federal Cannabis Legalization News | Safter Banking Act Update This week we saw a major push by Senate Majority Leader Chuck Schumer to legalize cannabis at the federal level when he circulated a petition, asking for signatures from supporters. These types of email campaigns are often used to build up their own email lists for political fundraising; however, Schumer has been an outspoken proponent of allowing banks to do business in the cannabis industry. On Wednesday, Schumer and a bipartisan group of cannabis supporters introduced a revised version of the SAFE Banking Act called the SAFER Banking Act. This updated version has some new provisions and is set for mark-up in the Senate next week. Meanwhile, two republican supporters of the SAFER Banking Act introduced their own bill to impede the proposition of rescheduling cannabis to a less regulated class. The DEA Act, as it’s known, would require congressional approval to propose a change to any federal drug law, adding another hurdle to the prospect of cannabis legalization if it were to pass both chambers of Congress. The MORE Act was also refiled again this week, making its way to the House for a third time. The bill is solely sponsored by Democrats and faces an uphill battle to make it through while the House is under GOP majority. New York continues to make headlines for their calamitous roll out of the adult-use industry in the state. Leafly, Ron DeSantis, and the NCAA also get some of the spotlight this week. Tune in to hear all about it. This is Cannabis Legalization News for the week of September 18th. Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz) #cannabisreform #cannabis #cannabislegalization

Federal rescheduling of cannabis has been a big topic in recent news. A government analysis predicts the DEA is likely to reschedule cannabis. The analysis, conducted by the Congressional Research Service (CRS), is based on the DEA's past practices and the HHS's recent recommendation to reschedule marijuana. The CRS analysis states that the DEA has historically been reluctant to reschedule marijuana, but that it has also shown a willingness to do so when there is strong scientific evidence to support the change. In this case, the HHS's recommendation is based on a comprehensive review of the scientific literature, which found that there is sufficient evidence to support the medical use of marijuana. The CRS analysis also notes that the DEA is currently facing a number of challenges, including budget cuts and increasing public pressure to reform its drug scheduling system. These factors could make the DEA more likely to reschedule marijuana, as it would be a way to show that the agency is responsive to public concerns. However, it is important to note that the CRS analysis is just a prediction. The DEA is not required to follow the HHS's recommendation, and it could ultimately decide to keep marijuana in Schedule I. The DEA is expected to make a decision on the scheduling of marijuana in the coming months. If the DEA does decide to reschedule marijuana, it would be a major victory for advocates of cannabis reform. It would make it easier for researchers to study the potential medical benefits of marijuana, and it would make it easier for doctors to prescribe marijuana to patients with certain conditions. It would also make it possible for banks to offer services to marijuana businesses, which would help to legitimize the industry. Here are some of the specific implications of rescheduling marijuana to Schedule III: •It would make it easier for researchers to study the potential medical benefits of marijuana. •It would make it easier for doctors to prescribe marijuana to patients with certain conditions. •It would make it possible for banks to offer services to marijuana businesses. •It would make it easier for people who use marijuana to obtain housing and employment. •It would have limited implications for state recreational marijuana programs and those who use marijuana recreationally. The decision of whether or not to reschedule marijuana is a complex one, and there are a number of factors that the DEA will need to consider. However, the HHS's recommendation is a significant step forward and could pave the way for further reforms in the future. Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz) #cannabisreform #cannabis #freetheplant Federal Rescheduling of Cannabis News 

Has a federal court legalized delta-8 THC with a recent federal court order that temporarily blocked the DEA from enforcing a rule that would have classified delta-8 THC as a controlled substance? The order was issued by a U.S. District Court judge in Washington, D.C., and it is still in effect. However, it is important to note that this is just a temporary order, and it is not yet clear whether the DEA will appeal the decision. If the DEA does appeal the decision, it is possible that the court could ultimately rule that delta-8 THC is a controlled substance. In that case, delta-8 THC would be illegal in all 50 states. Even if the DEA does not appeal the decision, it is still possible that some states could ban delta-8 THC. As of now, only 14 states have banned delta-8 THC, but other states could follow suit. So, the legal status of delta-8 THC is still uncertain. It is possible that it could be legal in all 50 states, but it is also possible that it could be illegal in some or all states. It is important to stay up-to-date on the latest developments in this area. Here are some additional things to keep in mind: The 2018 Farm Bill legalized hemp, which is defined as cannabis with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis. Delta-8 THC is a compound that occurs naturally in hemp, but it can also be produced synthetically. The DEA issued a rule in 2020 that would have classified delta-8 THC as a controlled substance. However, the rule was challenged in court, and the federal court order that I mentioned earlier blocked the DEA from enforcing the rule. The legal status of delta-8 THC is still evolving, and it is important to stay up-to-date on the latest developments.

The U.S. Department of Health and Human Services (HHS) recently recommended that cannabis be rescheduled from Schedule I to Schedule III under the federal Controlled Substances Act (CSA). Schedule I controlled substances are considered to have no currently accepted medical use and a high potential for abuse. Schedule III controlled substances are considered to have a moderate to low potential for abuse and a currently accepted medical use. The HHS recommendation is based on a scientific and medical review of cannabis that was conducted by the Food and Drug Administration (FDA). The FDA review found that there is "substantial evidence" that cannabis and cannabis-derived products are effective in treating certain medical conditions, such as chronic pain, nausea and vomiting associated with chemotherapy, and spasticity associated with multiple sclerosis. The HHS recommendation is non-binding, and the final decision on whether to reschedule cannabis will be made by the Drug Enforcement Administration (DEA). The DEA is expected to take several months to review the HHS recommendation and make a decision. If the DEA does reschedule cannabis to Schedule III, it would be a significant step forward for the cannabis industry. It would make it easier for researchers to study cannabis and for doctors to prescribe it to patients. It would also make it easier for businesses to sell and distribute cannabis products. However, even if the DEA reschedules cannabis to Schedule III, it would still be illegal to possess, distribute, or manufacture cannabis under federal law. The only way to make cannabis legal under federal law would be for Congress to pass a law specifically legalizing it. The HHS recommendation is a positive development for the cannabis industry, but it is important to remember that it is just a recommendation. The DEA has the final say on whether to reschedule cannabis, and it is possible that the DEA will decide to keep cannabis in Schedule I. Only time will tell what the DEA will decide. However, the HHS recommendation is a significant step forward, and it is a sign that the federal government is slowly starting to come to terms with the reality of cannabis. Here are some of the potential benefits of rescheduling cannabis to Schedule III: It would make it easier for researchers to study cannabis and for doctors to prescribe it to patients. It would make it easier for businesses to sell and distribute cannabis products. It could reduce the number of people who are incarcerated for cannabis-related offenses. It could generate tax revenue for the government.

#Cannabis #Legalization #News is a professional and informative podcast that serves as the ultimate source for all the latest news and updates on the cannabis industry. Hosted by Tom & Miggy; the show aims to empower listeners by providing accurate and up-to-date information about cannabis legalization. The podcast explores a wide range of topics, including industry trends, regulatory changes, financial protection for cannabis businesses, social equity, workplace policies, and the balance between regulation and personal freedom. With expert analysis and thought-provoking discussions, Cannabis Legalization News is a go-to resource for licensed operators and enthusiasts seeking valuable insights into the ever-evolving landscape of cannabis legislation. Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz) Cannabis Legalization News is committed to keeping its audience informed and engaged, making it an invaluable resource for staying up-to-date with the latest developments in the cannabis industry. Please note that the views expressed in the podcast are for informational purposes only and should not be considered legal advice. Listeners are advised to consult with qualified professionals before making any decisions regarding cannabis use or legal matters.

The DEA has recently confirmed that it believes delta-8 THC synthesized from CBD is federally illegal. This is based on a 2021 letter from DEA's Drug & Chemical Evaluation Section Chief Terrence Boos. Boos states, “Arriving at delta-8-THC by a chemical reaction starting from CBD makes the delta-8-THC synthetic and therefore, not exempted by the Agriculture Improvement Act. Any quantity of delta-8-THC obtained by chemical means is a controlled substance.” Hemp itself is considered a legal agricultural product under the 2018 Farm Bill. The DEA's position is based on the Controlled Substances Act (CSA), which defines a "synthetic drug" as "a drug that is not naturally occurring and that is chemically made." The DEA argues that delta-8 THC is not naturally occurring in hemp, and that it is therefore a synthetic drug. The DEA's position is controversial, and there is some legal debate about whether it is correct. However, the DEA has the authority to enforce the CSA, and it is likely that they will continue to pursue cases against businesses that sell delta-8 THC synthesized from CBD.

The New York State Supreme Court granted a temporary injunction this week that prevents the Office of Cannabis Management (OCM) from issuing and approving retail marijuana licenses to social equity applicants, which could potentially delay hundreds of conditional adult-use retail dispensary (CAURD) operators from opening for months. A recent lawsuit filed by a group of disabled military veterans in New York states that the state’s system of awarding and issuing licenses to certain social equity applicants violated their constitutional rights. The suit alleges that the Office of Cannabis Management and Cannabis Control Board overstepped the authority of the state when the CAURD program was created. Hundreds of licenses hang in the balance leaving the license holders wondering whether the injunction will become permanent and render their entire investment a loss. Many were days away from opening their doors to the public when the injunction occurred. Tune in to this week’s episode of Cannabis Legalization News to find out more about this developing story as well as other top news for the week including the 2023 Farm Bill, another lawsuit in Arkansas, a recall of cannabis gummies, and much more. Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj) 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz) #cannabis #farmbill2023 #cannabisbusiness

The Biden Administration's recent decision to allow VA doctors to discuss medical marijuana usage with veterans is an important step forward for cannabis reform in the US. In the past, VA doctors were not allowed to even mention medical marijuana due to federal restrictions, so this change marks a major shift in policy. This has been welcomed by veteran advocacy groups as a way of helping those who have served our country and may be suffering from chronic conditions that could be improved with medical marijuana treatment. It also reflects a broader trend of increasing acceptance of cannabis in the US, as more states legalize recreational and medical use every year. Biden's decision will likely help encourage further development of research on how cannabis can help treat conditions such as post-traumatic stress (PTSD), chronic pain, depression, and anxiety in veterans. Some things Veteran need to know about marijuana and the VA: Veterans will not be denied VA benefits because of marijuana use. Veterans are encouraged to discuss marijuana use with their VA providers. VA health care providers will record marijuana use in the Veteran's VA medical record in order to have the information available in treatment planning. As with all clinical information, this is part of the confidential medical record and protected under patient privacy and confidentiality laws and regulations. VA clinicians may not recommend medical marijuana. VA clinicians may only prescribe medications that have been approved by the U.S. Food and Drug Administration (FDA) for medical use. At present most products containing tetrahydrocannabinol (THC), cannabidiol (CBD), or other cannabinoids are not approved for this purpose by the FDA. VA clinicians may not complete paperwork/forms required for Veteran patients to participate in state-approved marijuana programs. VA pharmacies may not fill prescriptions for medical marijuana. VA will not pay for medical marijuana prescriptions from any source. VA scientists may conduct research on marijuana benefits and risks, and potential for abuse, under regulatory approval. The use or possession of marijuana is prohibited at all VA medical centers, locations and grounds. When you are on VA grounds it is federal law that is in force, not the laws of the state. Veterans who are VA employees are subject to drug testing under the terms of employment.

Cannabis Legalization News: Progress on the State Level, Despite Federal Setback Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj) 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz) The cannabis legalization movement is facing a setback at the federal level, but there is still plenty of reason to be optimistic. In this week's news, we'll take a look at the latest developments in the fight for legalization, including: A bipartisan spending bill amendment that would have assessed the regulatory framework in states that have already legalized was shot down by the House Appropriations Committee. However, this does not mean that federal legalization is dead in the water. There are still a number of bills that are being considered in Congress, and it is possible that one of them could pass in the near future. Maryland finalized their numbers from the first week of sales, showing that the state has already generated over $1 million in tax revenue. This is a significant amount of money, and it shows that the cannabis industry can be a major source of revenue for states. Michigan is seeing a decline in opioid-related deaths, which some experts attribute to the state's legalization of medical marijuana. This is a promising development, as it suggests that cannabis can be a safe and effective alternative to opioids for pain relief. The number of federal marijuana prisoners has declined since states began to legalize the plant. This is a positive step, as it means that fewer people are being incarcerated for non-violent drug offenses. However, there are still concerns about illegal farms and untracked products being found on dispensary shelves in New Mexico and California. These are important issues that need to be addressed as the cannabis industry continues to grow. Despite the setback at the federal level, the cannabis legalization movement is still making progress. With more and more states legalizing the plant, it's only a matter of time before federal legalization becomes a reality. Here are three hashtags that you can use to optimize your YouTube video for SEO: #cannabislegalization #cannabisnews #marijuanareform

#cannabis #cannabisnews #cannabisindustryThe proposed amendment to the NDAA by Rep. Matt Gaetz is a controversial one, but it is one that is gaining traction as more and more states legalize marijuana. The amendment would end cannabis testing for members of the military, both when they are enlisting and accepting a commission. There are several arguments in favor of the amendment. First, it would address the growing number of recruits who test positive for marijuana use. In 2022, nearly 33% more recruits tested positive than in 2020. This is likely due to the increasing number of states where marijuana is legal. If the amendment is passed, it would allow the military to focus on recruiting qualified individuals, rather than disqualifying them for past marijuana use. Second, the amendment would help to address the military's recruitment and retention crisis. The military is facing a shortage of recruits, and this amendment could help to attract more people to serve. Many people who use marijuana do not use it while they are actively serving, and they would be able to join the military if they were not disqualified for past use. However, there are also several arguments against the amendment. First, some people believe that marijuana use is still illegal under federal law, and that the military should not allow it. Second, some people worry that the amendment would lead to an increase in marijuana use in the military. However, there is no evidence to suggest that this would be the case. In fact, studies have shown that marijuana use does not impair military performance. Overall, the proposed amendment to the NDAA is a complex issue with both pros and cons. It is important to weigh all of the arguments before making a decision about whether or not to support it. Here are some additional points to consider: The amendment would not allow members of the military to use marijuana while they are on duty. The amendment would not allow members of the military to use marijuana in states where it is illegal. The amendment would still allow the military to test for marijuana use if there is reasonable suspicion that someone is using it. It is still too early to say whether or not the amendment will be passed. However, it is an issue that is being debated, and it is likely to continue to be discussed in the coming months and years. #cannabis #cannabisnews #cannabisindustry Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj) 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz)Cannabis News Clips - CLN backup channel743 subscribers Videos  About Show less 0 Comments Sort bycloudAdd a comment...

This week in Cannabis Legalization News, the US Cannabis Council (USCC) launched a new super PAC called Legalize America on June 28, 2023. The super PAC is the first of its kind in the cannabis industry, and it is funded by a coalition of leading cannabis companies and advocacy groups. Legalize America's goal is to end the federal prohibition of cannabis and advance reform at the state and local levels. The super PAC will focus on a number of areas, including: Public education: Legalize America will work to educate the public about the benefits of cannabis legalization and the harms of prohibition. Advocacy: Legalize America will advocate for cannabis reform at the federal, state, and local levels. Grassroots organizing: Legalize America will organize grassroots support for cannabis reform. Electioneering: Legalize America will support candidates who are committed to cannabis reform. The launch of Legalize America is a significant development in the fight for cannabis reform. The super PAC has the potential to raise a significant amount of money and to mobilize a large number of voters. If successful, Legalize America could help to end the War on Drugs and to create a more just and equitable cannabis industry. Here are some additional details about Legalize America: The super PAC is chaired by Matt Harrell, vice president of government relations for Curaleaf. The secretary of the super PAC is Pete Meachum, vice president for government relations for Cronos Group. Legalize America has a budget of $10 million. The super PAC plans to focus its efforts on the 2024 elections. Legalize America is a sign of the growing momentum for cannabis reform in the United States. With the super PAC's work, it is possible that we will see federal legalization in the near future. Check out this story and others that topped our list of the week’s biggest news. Don’t forget to hit like and subscribe for more cannabis legalization content! #cannabisreform #cannabislegalization #cannabisbusiness